We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$269M
AUM Growth
–
Cap. Flow
+$264M
Cap. Flow %
98.02%
Top 10 Hldgs %
27.65%
Holding
112
New
112
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CLDX icon
Celldex Therapeutics
CLDX
+$10.8M
2
RH icon
RH
RH
+$10.3M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.56M
4
AAPL icon
Apple
AAPL
+$6.29M
5
EPD icon
Enterprise Products Partners
EPD
+$6.18M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Energy 19.28%
3 Communication Services 12.18%
4 Industrials 9.72%
5 Technology 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
101
Freeport-McMoran
FCX
$110B
$210K 0.08%
+7,600
New +$232K
TI
102
DELISTED
Telecom Italia
TI
$80K 0.03%
+11,500
New +$89.3K
ACCO icon
103
Acco Brands
ACCO
$396M
$69K 0.03%
+10,853
New +$73.3K
SSKN
104
DELISTED
Strata Skin Sciences
SSKN
$38K 0.01%
+83
New +$44.5K
1 2 3 4
5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Private Capital Advisors, which disclosed 112 positions worth $269M. Its ten largest holdings account for 28% of the portfolio.

Its largest position is Celldex Therapeutics: 54,837 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Energy and Communication Services.

  • Private Capital Advisors's largest Q2 2013 buy was Celldex Therapeutics: 54,837 shares worth $12.8M.
  • Private Capital Advisors's ten largest holdings make up 28% of its $269M portfolio in Q2 2013.
  • Private Capital Advisors disclosed 112 positions in Q2 2013, its first 13F filing on record.

Based on Private Capital Advisors's 13F filing for Q2 2013, filed 24 Jul 2013.